Table 3 Genetic pattern of non-syndromic PIDs among genetically resolved Eastern Iranian patients.

From: Genetic and epidemiological patterns of primary immunodeficiency diseases in Eastern Iranian patients

Gene

State (Inheritance)

Variations

Type

Gene (NM_ID)

SNP-ID

MAF

AP1

exon

Classification (ACMG criteria)

change

Publication No

Associated disease (omim)

ARHGEF1

Homo (AR)

c.1480G > T (p.Asp494Tyr)

M

NM_004706.4

N/A

D

16

VUS (PM2, PP3)

NO

Novel

IMD62 (618,459)

BTK

Hem (XLR)

c.37C > T (p.Arg13Ter)

N

NM_000061.3

rs128620187

N/A

N/A

2

P (PVS1, PM3, PM2, PP5)

NO

11

XLA (300,755)

BTK

Hem (XLR)

c.763C > T (p.Arg255Ter)

N

NM_000061.2

rs128621193

N/A

N/A

8

P (PVS1, PM2, PM3, PP5)

NO

16

IMD1 (300,755)

C1QA

Homo (AR)

c.159G > T (p.Glu53Asp)

M

NM_015991.4

rs750646958

Absent

B

2

VUS (PM2, BP4)

NO

Novel

C1QD1 (613,652)

CARD9

Homo (AR)

c.883C > T ( p.Gln295*)

N

NM_052813.5

rs121918338

Absent

N/A

6

P (PVS1, PM3, PM2, PP5)

NO

Novel

IMD103 (212,050)

CARMIL2

Homo (AR)

c.871 + 1G > T

S

NM_001013838.3

N/A

D

11

P (PVS1, PM2, PM3, PP5)

NO

1

IMD58 (618,131)

CARMIL2

Homo (AR)

c.871 + 1G > T

S

NM_001013838.3

rs886041044

Absent

D

11

P (PVS1, PM3, PM2, PP5)

NO

1

IMD58 (618,131)

CD3E

Homo (AR)

c.103 + 1G > A

S

NM_000733.4

rs201543770

Absent

D

5

LP (PVS1, PM2, PP5)

NO

2

IMD18 (615,615)

CR2

Homo (AR)

c.1777 T > G (p.Cys593Gly)

M

NM_001006658.3

––

N/A

D

10

VUS (PM2, PP3)

NO

Novel

CVID7 (614,699)

CYBB

Hem (XLR)

c.536G > T (p.Gly179Val)

M

NM_000397.4

N/A

N/A

6

LP (PVS1, PM2 , PM5)

NO

Novel

CGDX (306,400)

CYBB

Hem (XLR)

c.1465_1466insC (p.Asn489fs)

Ins

NM_000397.4

N/A

N/A

12

LP (PVS1, PM2 )

NO

Novel

CGDX (306,400)

ICOS

Homo (AR)

c.334 T > C (p.Ser112Pro)

M

NM_012092.4

N/A

U

2

VUS (PM2)

NO

Novel

CVID1 (607,594)

IFNGR1

Homo (AR)

c.254G > A (p.Cys85Tyr)

M

NM_000416.2

N/A

D

3

VUS (PM2, PP3)

NO

1

IMD27A (209,950)

IFNGR1

Homo (AR)

c.55dupA (p.met19Asnfs Ter16)

Ins

NM_000416.3

N/A

N/A

1

LP (PVS1, PM2)

NO

Novel

IMD27A (209,950)

IKBKB

Homo (AR)

c.201-1G > A

S

NM_001556.3

N/A

D

4

LP (PVS, PM2)

NO

Novel

IMD15B (615,592)*

IKBKB

Het (AD)

c.1654A > G (p.Met552Val)

M

NM_001556.3

rs200018957

Absent

U

16

VUS (PM2)

NO

Novel

IMD15A (618,204)

IKBKB

Homo (AR)

c.201-1G > A

S

NM_001556.3

N/A

D

4

LP (PVS, PM2)

NO

Novel

IMD15B (615,592)

IL12B

Homo (AR)

c.282dupC (p.Glu95ArgfsTer21)

Dup

NM_002187.3

N/A

N/A

3

LP (PVS1PM2)

NO

Novel

IMD29 (614,890)

IL12RB1

Homo (AR)

c.509 T > A (p.Val170Glu)

M

NM_005535.3

N/A

U

5

VUS (PM2, PM3, PP5)

NO

Novel

IMD30 (614,891)

IL12RB1

Homo (AR)

c.629 T > A (p.Val210Glu)

M

NM_001290024.1

N/A

U

5

VUS (PM2, PM3, PP5)

NO

Novel

IMD30 (614,891)

IL2RG

Hem (XLR)

c.670C > T (p.Arg224Trp)

M

NM_000206.3

rs869320658

N/A

D

5

P (PM1,PM2,PM5,PS4,PP3,PS3,PP4,PP5)

NO

9

SCIDX1 (300,400)*

IL2RG

Homo (AR)

c.664C > T (p.Arg222Cys)

M

NM_000206.3

N/A

D

5

P (PP1, PM2, PM5, PM1, PP4, PS4, PP3, PP5)

NO

24

SCIDX1 (300,400)

IL7R

Homo (AR)

c.537 + 1G > A

S

NM_002185.5

rs777878144

Absent

D

4

P (PVS1, PM3, PM2, PP5)

NO

3

IMD104 (608,971)

IL7R

Homo (AR)

c.358delA (p.Ile121fs)

Del

NM_002185.5

N/A

N/A

3

LP (PVS1, PM2)

NO

Novel

IMD104 (608,971)*

JAK3

Homo (AR)

c.184 + 1G > T

S

NM_000215.4

N/A

D

2

LP (PVS1, PM2 )

NO

Novel

SCID (600,802)

MALT1

Homo (AR)

c.571C > T (p.Arg191Ter)

N

NM_006785.4

rs1266114717

Absent

N/A

4

P (PVS1, PM2 , PP5)

NO

2

IMD12 (615,468)

MALT1

Homo (AR)

c.1454A > G (p.Asn485Ser)

M

NM_006785.4

N/A

U

12

VUS (PM2)

NO

Novel

IMD12 (615,468)

MSN

Hem (XLR)

c.1141C > T (p.Arg381Cys)

M

NM_002444.3

rs754305867

Absent

U

10

VUS (PM2)

NO

Novel

IMD50 (300,988)

NCF1

Homo (AR)

c.125G > A (p.Arg42Gln)

M

NM_000265.7

rs119103270

Absent

D

2

P (PM3,PP3,PM2,PM5,PP5)

NO

2

CGD1 (233,700)

RAG1

Homo (AR)

c.2688G > A (p.Trp896Ter)

N

NM_000448.2

N/A

N/A

2

VUS

LP (PVS1PM2)

1

SCID (601,457)

RAG1

Homo (AR)

c.2210G > A (p.Arg737His)

M

NM_000448.3

rs104894286

Absent

D

2

P (PM3PM2PM5PM1PP3PP2PS3PP5)

NO

9

SCID (601,457)*

RAG1

Homo (AR)

c.2893G > C (p.Glu965Gln)

M

NM_000448.3

N/A

U

2

VUS (PM2PM1PP2)

NO

Novel

SCID (601,457)

RAG2

Homo (AR)

c.130G > A (p.Gly44Arg)

M

NM_000536.4

Absent

D

2

VUS (PM1, PM2, PP3, PP2)

NO

Novel

SCID (601,457)

RAG2

Homo (AR)

c.200G > T (p.Cys67Phe)

M

NM_000536.4

N/A

D

2

VUS (PM2,PP3,PM1,PP2)

NO

Novel

SCID (601,457)

SH2D1A

Hem (XLR)

c.32 T > A (p.Ile11Asn)

M

NM_002351.5

N/A

N/A

1

VUS (PM2,PP3,PM1,PP2)

NO

Novel

XLP2 (308,240)

TLR3

Het (AD / AR)

c.2656_2657insTAGG (p.A888Rfs*5)

Ins

NM_003265.3

N/A

N/A

5

VUS (PM2)

NO

Novel

IMD83 (613,002)

TNFRSF13B

Het (AD / AR)

c.704_705delCT (p.Pro235ArgfsTer169)

Del

NM_012452.3

rs749017984

 < 0.01

N/A

5

VUS

LP (PVS1, PM2)

2

CVID2 (240,500)

  1. AD, autosomal dominant; AP, aggregated prediction; AR, autosomal recessive; D, deleterious; Del, deletion; Hem, hemizygote; Het, heterozygote; Hom, homozygote; Ins, insertion; LP, likely pathogenic; M, missense; MAF, minor allele frequency; N, nonsense; N/A, not available; P, pathogenic; S, splicing; Syn, synonymous; U, uncertain; VUS, Variants of unknown significance; XL/R, X-linked/recessive; IMD, Immunodeficiency; IMD83, Immunodeficiency 83 susceptibility to viral infections; C1QD1, C1q deficiency 1; IMD103, immunodeficiency 103 susceptibility to fungal infections; SCIDX1, X-linked Severe combined immunodeficiency; CVID, common variable immunodeficiency; XLP2, X-linked Lymphoproliferative syndrome 2; CGDX, X-linked chronic granulomatous disease; IMD, immunodeficiency; IMD14A, immunodeficiency 14A with lymphoproliferation autosomal dominant; XLA, agammaglobulinemia X-linked; CGD1, chronic granulomatous disease-1.
  2. 1Aggregated Prediction (AP) reported in the Franklin database depends on the ensemble methods, including REVEL and MetaLR, which allocate different weights to the various in silico tools. This might generate scenarios where the aggregated prediction can be ‘benign’ or ‘uncertain significance’, while several tools would give the variants a ‘deleterious’ score or vice-versa.
  3. 2Classification according to ACMG guideline.
  4. *Asterisked associated diseases have been reported in fetus.